We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

About ManageMR

Provides personalized referral and treatment advice for mitral regurgitation.

ManageMR provides clinicians with personalized referral and treatment advice for diagnosed mitral regurgitation patients by verifying the severity and etiology of the MR.

• Enter patient parameters from an echo assessment.

• Review customized advice on

- Probable severity and etiology of a patient’s MR

- Need for referral

- Feasibility of mitral valve repair vs. replacement for the patient

Content in this app is derived from the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation. The information and advice in this app are meant to support clinical decision making. They are not meant to represent the only or best course of care, or replace clinical judgment. Therapeutic options should be determined after discussion between the patient and their care provider. ManageMR is part of the ManageMR Toolkit supported by Founding Sponsor Abbott Vascular.

What's New in the Latest Version 2.0

Last updated on Apr 9, 2020

The ManageMR app is now updated with content from the 2020 Focused Update of the 2017 Expert Consensus Decision Pathway on the Management of Mitral Regurgitation.

Translation Loading...

Additional APP Information

Latest Version

Request ManageMR Update 2.0

Uploaded by

Ni Soe Linn

Requires Android

Android 4.4+

Available on

Get ManageMR on Google Play

Show More

ManageMR Screenshots

Also available for other platforms

Languages
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.